Task: Answer Verification
Input (English): Question: Does eRRα be a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer?
Answer: Taken together, these data show that ERRα expression predicts response to tamoxifen treatment, and ERRα could be a biomarker of tamoxifen sensitivity and a prognostic factor in TNBC.
Output (English): yes